After the
mass vaccination of the teens and adults. The government next target are the
children with ages 11-5. During the surge of COVID-19, 110,609 cases and 1,916
confirmed hospitalized were young children aged 5-11 contributed 3.49% cases
from March 2022 up until January 2022. The vaccination has already started
nationwide and the HTAC recommended that P-fizer-BioNTech Vaccine is suitable
for young children with the age of 5-11.
The
Philippine government had ordered around 30 million of vaccine doses and 2.6 %
have been delivered with a total of 78,000 doses. The Department of health had
stated that a global data had showed that there was no death attributed among
the pediatric population world wide. Furthermore, over 99% among the individuals
aged 12-17 years old were noted to be no experiences of post-vaccination
symptoms. The Department of Health with Philippine Pediatric Society and the
Pediatric Infectious Disease Society of the Philippines had stated that the
virus’ effect in children is less severe than the adults though it could still
lead to hospitalization. Around 3% of cases and 0.5 % of death deaths from the
virus among pediatric population were reported by the organizations. The
Pfizer-BioNTech vaccine can lessen the number of infections among the children
with ages 5-11 years old. It can prevent symptomatic and severe effects of COVID-19. A study also
proved that vaccination of the pediatric population could develop a quality of
life within a home when guardians of these children are relieved of dealing the
effects of COVID-19 infection. This implementation has brought the potential of
reopening of the schools that could improve the psychosocial well-being of the
said population.
Execution
of mass vaccination of the pediatric population can improve their well-being
and it the ability to go back to normal has already a potential. The
government’s implementation has brought hopes and safety to the children and
also to the adults.
No comments:
Post a Comment